Key facts
- Gentueri’s last known valuation is $2.0M (Mar 2019).
- It has raised $1.2M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Wisconsin Economic Development, Winnebago Seed Fund, Winnow Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Gentueri
- ·The full record, as it builds
Funding rounds
No funding rounds for Gentueri are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gentueri
Developer of a clinical device designed to work with genetic testing and crime laboratories. The company's device aids in collecting and reporting DNA evidence, identification and preservation of biological evidence, tracking crime scenes and sexual assaults, preserves swabs from the point of collection through shipping, room temperature storage, and initial processing of biological samples, enabling forensics to get accurate readings when doing genetic tests and DNA analysis.
- Sector
- Healthcare
- HQ
- Verona, WI, United States
- Founded
- 2012
- Employees
- 11
- Website
- gentueri.com/
- Ownership
- Privately Held (backing)
Gentueri doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gentueri shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gentueri in its N-PORT filings yet. We sweep new filings monthly.